PGI/PGII Rapid Quantitative Test

Human pepsinogens I (PGI) and II (PGII) are proenzymes of pepsin—an endoproteinase of gastric juice. PGI is secreted mainly by chief cells in the fundic mucosa, whereas PGII is also secreted by the pyloric glands and the proximal duodenal mucosa. Serum PGI and PGII concentrations and the ratio between PGI and PGII may be related to the histologic and functional status of the gastric mucosa.

PGI Rapid Quantitative Test

Human Pepsinogens are aspartic proteases produced in the gastric mucosa and secreted into the gastric lumen that play a major role in the digestion of proteins after activation of acidic pH. It is synthesized as isoymogens and is classified into two groups (Pepsinogen I and Pepsinogen II).

PGII Rapid Quantitative Test

Myo Rapid Quantitative Test

Myo is the earliest marker after AMI, and it is a sensitive and accurate indicator to judge whether there is reperfusion in thrombolytic therapy. Biotime Myo test kit is mainly used to detect Myo quantity in human serum and plasma samples.

HbA1c Rapid Quantitative Test

HbA1c is the product of the hemoglobin combining with blood glucose in red blood cells, which can reflect the average blood glucose level over the amid 2-3 months.

25(OH)-D Rapid Quantitative Test

25（OH）-D is a prehormone that is produced in the liver by hydroxylation of vitamin D3 (cholecalciferol) by the enzyme cholecalciferol 25-hydroxylase. Physicians worldwide measure this metabolite to determine a patient's vitamin D status.

BIOT-YG-I FIA Analyzer (Fluorescence Immunoassay Analyzer)

BIOT-YG-I is a fluorescence immunoassay system with single channel that measures the quantitative concentration of a targeted analyte in human blood and urine.

3 in 1 (cTnI/CK-MB/Myo) Rapid Quantitative Test

3 in 1 test kit has a very high specificity and sensitivity for the detection of AMI, making a correct and timely diagnosis for patients with chest pain or clinically suspected AMI, and thus providing validly basis for clinicians with prompt rescue and treatment.

HBP Rapid Quantitative Test (Chemiluminescence Immunoassay)

HBP Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the Heparin binding protein (HBP) concentration in human plasma that contains Sodium Citrate samples, mainly used for auxiliary diagnosis of inflammation diseases.

Specimen Types	Serum
Specimen Capacity	10μL
Reaction Time	15 min
Sample Capacity	80μL
Detection Range	Same as individual item

Fluorescence Immunoassay

Gastrointestinal Marker

PGI/PGII Rapid Quantitative Test